Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase-II-Trial of Evaluation of Acute Toxicity in Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer

NCT01948726 is registered in ClinicalTrials.gov with University Hospital Schleswig-Holstein as lead sponsor.

NCT NCT01948726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01948726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase-II-Trial of Evaluation of Acute Toxicity in Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer
Lead sponsor
University Hospital Schleswig-Holstein
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2013
Completion date
March 31, 2015
Enrollment
150 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer after breast conserving surgery indicating postoperative radiotherapy with boost